TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Urogyn Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/08 |
| Turnover |
377
|
469
|
390 |
| Financial expenses |
61
|
6
|
2 |
| Earnings before taxes |
-768
|
-45
|
463 |
| EBITDA |
-3,941
|
-3,718
|
-1,864 |
| Total assets |
2,085
|
1,923
|
1,673 |
| Current assets |
499
|
581
|
985 |
| Current liabilities |
692
|
666
|
265 |
| Equity capital |
150
|
829
|
1,277 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
6
|
23
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/08 |
| Solvency |
7.2%
|
43.1%
|
76.3% |
| Turnover per employee |
63
|
20
|
28 |
| Profit as a percentage of turnover |
-203.7%
|
-9.6%
|
118.7% |
| Return on assets (ROA) |
-33.9%
|
-2.0%
|
27.8% |
| Current ratio |
72.1%
|
87.2%
|
371.7% |
| Return on equity (ROE) |
-512.0%
|
-5.4%
|
36.3% |
| Change turnover |
-76
|
93
|
76 |
| Change turnover % |
-17%
|
25%
|
24% |
| Chg. No. of employees |
-17
|
9
|
1 |
| Chg. No. of employees % |
-74%
|
64%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.